Myotec Therapeutics Overview

  • Founded
  • 2006
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Merger of Eq.

Myotec Therapeutics General Information

Description

Developer of novel therapeutics for the treatment of cancer and other clinically unmet diseases. The company develops drugs for the treatment of cancer.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Primary Office
  • 154B Milton Park
  • Abingdon OX14 4SD
  • England, United Kingdom
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Myotec Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger of Equals 15-Dec-2010 00.000 Completed Generating Revenue
2. Early Stage VC (Series A) 08-Mar-2010 00.000 00.000 000.00 Completed Startup
1. Seed Round Completed Startup
To view Myotec Therapeutics’s complete valuation and funding history, request access »

Myotec Therapeutics Executive Team (1)

Name Title Board Seat Contact Info
Stefan Anker Ph.D Scientific Founder
To view Myotec Therapeutics’s complete executive team members history, request access »

Myotec Therapeutics Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Invesco Perpetual Asset Manager Minority 000 0000 000000 0
Touchstone Innovations Venture Capital Minority 000 0000 000000 0
To view Myotec Therapeutics’s complete investors history, request access »

Myotec Therapeutics Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 0000000000 01-Jan-2010 000000 00 000000 Biotechnology
To view Myotec Therapeutics’s complete acquisitions history, request access »